N-[5-(2-fluoroethoxy)-4,6-dimethoxypyrimidin-2-yl]-6-methyl-7-pyrazol-1-yl-1H-indole-3-sulfonamide
C20H21FN6O5S — CID 175981658
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-(2-fluoroethoxy)-4,6-dimethoxypyrimidin-2-yl]-6-methyl-7-pyrazol-1-yl-1H-indole-3-sulfonamide
N-[5-(2-fluoroethoxy)-4,6-dimethoxypyrimidin-2-yl]-6-methyl-7-pyrazol-1-yl-1H-indole-3-sulfonamide (PubChem CID 175981658) has the molecular formula C20H21FN6O5S and a molecular weight of 476.49 g/mol. Its IUPAC name is N-[5-(2-fluoroethoxy)-4,6-dimethoxypyrimidin-2-yl]-6-methyl-7-pyrazol-1-yl-1H-indole-3-sulfonamide.
Molecular Properties
| Compound Name | N-[5-(2-fluoroethoxy)-4,6-dimethoxypyrimidin-2-yl]-6-methyl-7-pyrazol-1-yl-1H-indole-3-sulfonamide |
|---|---|
| PubChem CID | 175981658 |
| Molecular Formula | C20H21FN6O5S |
| Molecular Weight | 476.49 g/mol |
| Exact Mass | 476.13 |
| IUPAC Name | N-[5-(2-fluoroethoxy)-4,6-dimethoxypyrimidin-2-yl]-6-methyl-7-pyrazol-1-yl-1H-indole-3-sulfonamide |
| SMILES | COc1nc(NS(=O)(=O)c2c[nH]c3c(-n4cccn4)c(C)ccc23)nc(OC)c1OCCF |
| InChI | InChI=1S/C20H21FN6O5S/c1-12-5-6-13-14(11-22-15(13)16(12)27-9-4-8-23-27)33(28,29)26-20-24-18(30-2)17(32-10-7-21)19(25-20)31-3/h4-6,8-9,11,22H,7,10H2,1-3H3,(H,24,25,26) |
| InChIKey | HGWOMOPKEKCWKA-UHFFFAOYSA-N |
| XLogP | 2.62 |
| TPSA | 133.25 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.49 |
| LogP ≤ 5 | 2.62 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175981658 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.